-
Mashup Score: 0First ASTRO Clinical Guideline for Anal Cancer Focuses on Radiotherapy, Surveillance Strategies for Patients - 7 day(s) ago
Read the full article here
Tweet
GI Oncology Now
Oncology / HematologyGI Oncology Now delivers comprehensive coverage of the latest advancements in gastrointestinal oncology, from novel therapies and clinical trials to conference updates and emerging technologies. We aim to equip oncology professionals with the knowledge needed to enhance patient care and optimize treatment outcomes.
-
Mashup Score: 5BREAKWATER: Encorafenib, Cetuximab, and Chemotherapy for Mutant Metastatic Colorectal Cancer | Docwire News - 1 month(s) ago
Scott Kopetz, MD, PhD, of MD Anderson Cancer Center, discusses the BREAKWATER study on the use of first-line encorafenib plus cetuximab with or without chemotherapy.
Source: docwirenews.comCategories: General Medicine News, UrologyTweet-
📺 Check out our interview with @skopetz of @MDAndersonNews on the phase 3 BREAKWATER study. 👉 The study analyzed 1L #encorafenib and #cetuximab with FOLFOX against standard-of-care chemotherapy alone for BRAF V600E-mutant metastatic #colorectal cancer: https://t.co/fixAtCvsn4 https://t.co/5JdJxwssUp
-
-
Mashup Score: 1New Insights From IDEA-France & HORG: The Prognostic Power of ctDNA and Immunoscore | Docwire News - 7 day(s) ago
Read the full article here
Tweet-
❇️ A recent post hoc analysis of the phase 3 IDEA-France and HORG trials has gleaned more information on the prognostic value of #immunoscore and #ctDNA as biomarkers in patients with #coloncancer who took part in the trials: https://t.co/yySI62LGQh
-
-
Mashup Score: 0
-
📺 Dr. Thierry André, head of the Medical Oncology Department at @HopSaintAntoine, discusses the CheckMate 8HW study presented at @ASCO #GI25 on #nivolumab plus #ipilimumab versus nivolumab monotherapy in MSI-H/dMMR metastatic colorectal cancer in a new interview: https://t.co/P7D8l1cw7A
Read the original tweet here
Tweet -
-
Mashup Score: 1
Dr. Marwan Fakih of City of Hope discusses the phase 2 study of botensilimab and balstilimab for the treatment of refractory microsatellite stable metastatic colorectal cancer.
Source: docwirenews.comCategories: General Medicine News, Partners & KOLsTweet-
📺 In a recent interview, Dr. @mgfakih of @cityofhope discusses the phase 2 study of #botensilimab + #balstilimab for the treatment of refractory microsatellite stable metastatic #colorectal cancer with no liver metastases that was presented at ASCO #GI25: https://t.co/ICqb5hLHds https://t.co/97mpSGW3zs
-
The American Society for Radiation Oncology has issued their first clinical guideline on anal cancer, focusing on the use of radiation therapy and planning for patients with the disease. The guideline seeks to clarify approaches to definitive treatment and surveillance.